Captrust Financial Advisors raised its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 4.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 112,489 shares of the company’s stock after acquiring an additional 4,995 shares during the quarter. Captrust Financial Advisors’ holdings in Colgate-Palmolive were worth $11,677,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $25,000. Continuum Advisory LLC grew its holdings in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter worth $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $53,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter worth $64,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Trading Down 0.1 %
Shares of CL stock opened at $96.63 on Monday. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The company has a market cap of $78.95 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 3.45 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock has a 50 day simple moving average of $97.38 and a 200-day simple moving average of $98.64.
Colgate-Palmolive Dividend Announcement
Analyst Ratings Changes
CL has been the subject of a number of research analyst reports. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price objective for the company. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. TD Cowen decreased their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $101.00 in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.
Insider Buying and Selling at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.34% of the company’s stock.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- What Are the FAANG Stocks and Are They Good Investments?
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Earnings Per Share Calculator: How to Calculate EPS
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What Investors Need to Know to Beat the Market
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.